(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman mesylate |
(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman methanesulfonate |
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE; METHA |
(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide; metha |
(4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE; METHANES |
(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxa |
(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate |
11032-41-0 |
511-12-6 (Parent) |
6190-39-2 |
81AXN7R2QT |
9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione mesylate |
9,10-Dihydroergotamine mesylate |
9,10-dihydroergotamine methanesulfonate |
910882-41-6 |
AC1L2FO7 |
AC1LAOVT |
AC1Q6WD6 |
ADYPXRFPBQGGAH-UMYZUSPBSA-N |
AKOS024282478 |
AN-21195 |
ANW-42737 |
C33H37N5O5.CH4O3S |
CCG-39548 |
CHEBI:59756 |
CHEMBL1200517 |
CHEMBL1396675 |
CS-2903 |
CTK8B3562 |
D 2763 |
D.H.E. 45 |
D02211 |
D0SP3D |
D2633 |
DETMS |
DHE-45 |
Dihydergot |
Dihydroergotamine (mesylate) |
Dihydroergotamine for peak identification, European Pharmacopoeia (EP) Reference Standard |
Dihydroergotamine mesilate |
Dihydroergotamine mesilate (JP17) |
Dihydroergotamine mesilate, European Pharmacopoeia (EP) Reference Standard |
Dihydroergotamine mesylate (USP) |
Dihydroergotamine mesylate [USAN:USP] |
Dihydroergotamine mesylate [USAN] |
Dihydroergotamine mesylate, United States Pharmacopeia (USP) Reference Standard |
Dihydroergotamine methanesulfonate |
Dihydroergotamine methanesulfonate salt |
Dihydroergotamine methanesulfonate salt, powder |
Dihydroergotamine monomethanesulfonate |
DIHYDROERGOTAMINE; METHANESULFONIC ACID |
Dihydroergotoxin |
DIHYDROERGOTOXINE |
Dihytamine |
DR003475 |
DR003476 |
EINECS 228-235-6 |
Ergoloid dihydroergotoxine |
Ergoloid Mesylates (dihydroergotoxine) |
Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy- 2'-methyl-5'-(phenylmethyl)-, (5'?,10?)-, monomethanesulfonate (salt) |
Ergotamine, 9,10-dihydro-, monomethanesulfonate (salt) |
Ergotamine, dihydro, methanesulfonate (salt) |
Ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, monomethanesulfonate (salt) |
EU-0100357 |
HMS1920G16 |
HMS2094K05 |
HMS2231H03 |
HMS3261G15 |
HMS3266C22 |
HMS3369K10 |
HMS501N14 |
HY-B0670A |
I14-101170 |
LP00357 |
LS-64558 |
MFCD00058615 |
mide methanesulfonate |
MLS002153175 |
MLS002207048 |
MolPort-003-666-163 |
MT 300 |
N-{7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL}-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE; METHANESULFONIC ACID |
NCGC00261042-01 |
Neomigran |
NSC-759848 |
NSC759848 |
Pharmakon1600-01500248 |
PL001844 |
PL041420 |
PL057923 |
Prestwick_746 |
rboxamide methanesulfonate(salt) |
SCHEMBL40843 |
SCHEMBL40844 |
SMR001230668 |
SPECTRUM1500248 |
SR-01000075382 |
SR-01000075382-1 |
ST056346 |
Tox21_500357 |
TR-021291 |
TRA0034972 |
UNII-81AXN7R2QT |
Z1544404034 |